1887

oa SA Pharmaceutical Journal - Onbrez Breezhaler® capsules (150 µg indacaterol maleate) : new product focus

Volume 81, Issue 7
  • ISSN : 2221-5875

 

Abstract

Onbrez Breezhaler® capsules are indicated as maintenance bronchodilator treatment for airflow obstruction in patients with chronic obstructive pulmonary disease (COPD).1 Each capsule of Onbrez Breezhaler® for inhalation contains the indacaterol maleate equivalent of 150 µg indacaterol and 24.8 mg lactose.

Loading full text...

Full text loading...

Loading

Article metrics loading...

/content/mp_sapj/81/7/EJC158614
2014-08-01
2017-04-29

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error